Profile | GDS5420 / 210812_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 117.62 | 44 |
GSM1296119 | B_lesional_pre-dose | 63.31 | 33 |
GSM1296076 | C_lesional_pre-dose | 52.22 | 31 |
GSM1296092 | D_lesional_pre-dose | 53.82 | 34 |
GSM1296103 | E_lesional_pre-dose | 107.89 | 43 |
GSM1296078 | F_lesional_pre-dose | 82 | 39 |
GSM1296107 | G_lesional_pre-dose | 71.73 | 34 |
GSM1296109 | H_lesional_pre-dose | 99 | 39 |
GSM1296080 | I_lesional_pre-dose | 103.37 | 44 |
GSM1296090 | J_lesional_pre-dose | 60.02 | 35 |
GSM1296074 | K_lesional_pre-dose | 76.93 | 40 |
GSM1296111 | L_lesional_pre-dose | 63.4 | 32 |
GSM1296099 | M_lesional_pre-dose | 98.02 | 41 |
GSM1296086 | O_lesional_pre-dose | 70.22 | 37 |
GSM1296117 | P_lesional_pre-dose | 65.68 | 32 |
GSM1296113 | Q_lesional_pre-dose | 96.06 | 37 |
GSM1296096 | R_lesional_pre-dose | 76.05 | 38 |
GSM1296105 | S_lesional_pre-dose | 77.76 | 37 |
GSM1296098 | T_lesional_pre-dose | 128.4 | 45 |
GSM1296101 | U_lesional_pre-dose | 63.37 | 34 |
GSM1296121 | V_lesional_pre-dose | 81.13 | 37 |
GSM1296088 | W_lesional_pre-dose | 105.98 | 43 |
GSM1296082 | X_lesional_pre-dose | 116.8 | 46 |
GSM1296115 | Y_lesional_pre-dose | 46.94 | 28 |
GSM1296084 | Z_lesional_pre-dose | 75.75 | 37 |
GSM1296072 | B_lesional_day8 | 71.7 | 35 |
GSM1296069 | L_lesional_day8 | 69.67 | 32 |
GSM1296071 | P_lesional_day8 | 85.94 | 36 |
GSM1296070 | Y_lesional_day8 | 40.1 | 24 |
GSM1296073 | V_lesional_day8 | 84.42 | 38 |
GSM1296034 | A_lesional_day15 | 52.07 | 30 |
GSM1296041 | G_lesional_day15 | 73.65 | 35 |
GSM1296035 | R_lesional_day15 | 107.47 | 43 |
GSM1296038 | U_lesional_day15 | 48.6 | 31 |
GSM1296047 | B_lesional_day15 | 101.66 | 40 |
GSM1296039 | E_lesional_day15 | 62.28 | 34 |
GSM1296042 | H_lesional_day15 | 53.66 | 29 |
GSM1296043 | L_lesional_day15 | 54.57 | 29 |
GSM1296037 | M_lesional_day15 | 62 | 33 |
GSM1296046 | P_lesional_day15 | 48.9 | 27 |
GSM1296044 | Q_lesional_day15 | 98.76 | 38 |
GSM1296045 | Y_lesional_day15 | 61.56 | 30 |
GSM1296025 | C_lesional_day15 | 123.19 | 45 |
GSM1296033 | D_lesional_day15 | 56.83 | 33 |
GSM1296027 | I_lesional_day15 | 31.99 | 27 |
GSM1296032 | J_lesional_day15 | 60.26 | 34 |
GSM1296024 | K_lesional_day15 | 100.5 | 42 |
GSM1296031 | W_lesional_day15 | 49.84 | 30 |
GSM1296028 | X_lesional_day15 | 83.71 | 39 |
GSM1296029 | Z_lesional_day15 | 46.98 | 31 |
GSM1296026 | F_lesional_day15 | 78.58 | 38 |
GSM1296030 | O_lesional_day15 | 55.8 | 36 |
GSM1296040 | S_lesional_day15 | 52.15 | 31 |
GSM1296036 | T_lesional_day15 | 96.44 | 39 |
GSM1296048 | V_lesional_day15 | 88.76 | 38 |
GSM1296059 | A_lesional_day43 | 65.95 | 36 |
GSM1296066 | G_lesional_day43 | 63.6 | 32 |
GSM1296060 | R_lesional_day43 | 114.99 | 44 |
GSM1296063 | U_lesional_day43 | 43.65 | 28 |
GSM1296064 | E_lesional_day43 | 105.49 | 43 |
GSM1296067 | H_lesional_day43 | 56.17 | 30 |
GSM1296062 | M_lesional_day43 | 73.61 | 37 |
GSM1296068 | Q_lesional_day43 | 65.48 | 31 |
GSM1296050 | C_lesional_day43 | 60.64 | 33 |
GSM1296057 | D_lesional_day43 | 78.79 | 38 |
GSM1296052 | I_lesional_day43 | 45.74 | 32 |
GSM1296054 | J_lesional_day43 | 59.18 | 33 |
GSM1296049 | K_lesional_day43 | 126.97 | 45 |
GSM1296055 | W_lesional_day43 | 53.02 | 31 |
GSM1296053 | X_lesional_day43 | 55.15 | 32 |
GSM1296058 | Z_lesional_day43 | 78.45 | 39 |
GSM1296051 | F_lesional_day43 | 55.72 | 33 |
GSM1296056 | O_lesional_day43 | 123.87 | 46 |
GSM1296065 | S_lesional_day43 | 61.74 | 34 |
GSM1296061 | T_lesional_day43 | 76.83 | 37 |
GSM1296095 | A_non-lesional_pre-dose | 54.13 | 33 |
GSM1296120 | B_non-lesional_pre-dose | 76.09 | 35 |
GSM1296077 | C_non-lesional_pre-dose | 46.58 | 31 |
GSM1296093 | D_non-lesional_pre-dose | 95.83 | 40 |
GSM1296104 | E_non-lesional_pre-dose | 87.81 | 39 |
GSM1296079 | F_non-lesional_pre-dose | 73.79 | 37 |
GSM1296108 | G_non-lesional_pre-dose | 74.56 | 35 |
GSM1296110 | H_non-lesional_pre-dose | 80.52 | 35 |
GSM1296081 | I_non-lesional_pre-dose | 45.26 | 32 |
GSM1296091 | J_non-lesional_pre-dose | 69.59 | 37 |
GSM1296075 | K_non-lesional_pre-dose | 55.77 | 33 |
GSM1296112 | L_non-lesional_pre-dose | 71 | 32 |
GSM1296100 | M_non-lesional_pre-dose | 48.91 | 30 |
GSM1296087 | O_non-lesional_pre-dose | 64.91 | 37 |
GSM1296118 | P_non-lesional_pre-dose | 80.57 | 35 |
GSM1296114 | Q_non-lesional_pre-dose | 73.27 | 33 |
GSM1296097 | R_non-lesional_pre-dose | 93.62 | 40 |
GSM1296106 | S_non-lesional_pre-dose | 70.74 | 35 |
GSM1296102 | U_non-lesional_pre-dose | 69.57 | 35 |
GSM1296122 | V_non-lesional_pre-dose | 61.21 | 31 |
GSM1296089 | W_non-lesional_pre-dose | 71.31 | 35 |
GSM1296083 | X_non-lesional_pre-dose | 107.92 | 43 |
GSM1296116 | Y_non-lesional_pre-dose | 76.73 | 33 |
GSM1296085 | Z_non-lesional_pre-dose | 55.51 | 32 |